Noninvasive imaging of the atherosclerotic burden in the advanced assessment of cardiovascular risk

Authors

Keywords:

aterosclerosis subclínica, aterotrombosis, técnicas de imagen no invasiva, diagnóstico por imagen, enfermedades cardiovasculares, factores de riesgo.

Abstract

Introduction: The detection and quantification of the atherosclerotic burden by non-invasive imaging techniques is a marker increasingly used in the evaluation and re-stratification of cardiovascular risk. The quantification of the atherosclerosis burden for the assessment of cardiovascular risk therefore requires a precise tool, since the risk increases proportionally to the burden of subclinical disease.
Objective: To deepen the non-invasive imaging techniques that allow the imaginological quantification of the global atherosclerotic burden in its subclinical phase and its importance in the early reassessment of cardiovascular risk.
Development: Among all imaging modalities, the coronary calcium score by computed tomography and the quantification of the atherosclerosis burden by three-dimensional vascular ultrasound have been shown to improve the assessment of individual cardiovascular risk above conventional risk scales based on presence of traditional risk factors, since it directly identifies the disease and reclassifies individuals at low and intermediate risk more effectively.
Conclusions: The non-invasive imaginological quantification of the atherosclerotic burden significantly improves the accuracy and precision in the prediction of the globally validated global cardiovascular risk estimation scales, as it increases their discrimination and reclassification capacity of the population at risk of cardiovascular disease.

Downloads

Download data is not yet available.

References

1. López-Melgar B. Ecografía vascular tridimensional, un nuevo método para la detección y la cuantificación de aterosclerosis subclínica. [Tesis doctoral]. España: Universidad Complutense de Madrid, Facultad de Medicina, Departamento Medicina; 2017. [acceso: 16/09/2019]. Disponible en: https://pdfs.semanticscholar.org/e04a/03a60cff00cc4b5f364131ea26b01cb474f4.pdf

2. López-Melgar B , Fernández-Friera L , Oliva B , García-Ruiz JM , Peñalvo JL , Gómez-Talavera S . Subclinical Atherosclerosis Burden by 3D Ultrasound in Mid-Life: The PESA Study. J Am Coll Cardiol. 2017 [acceso: 15/10/2019]; 70(3):301-13. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/28705310

3. Fernández-Friera L, Penalvo JL, Fernandez-Ortiz A, Ibañez B, Lopez-Melgar B, Laclaustra M, et al. Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study. Circulation. 2015[acceso: 16/09/2019]; 131(24):2104-13. Disponible en: https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.114.01431-0?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed

4. Joner M, Koenig W. Risk prediction by non-invasive coronary imaging: we are not there yet!. European Heart Journal. 2018 [acceso: 18/10/2019]; 39(11):942-44. Disponible en: https://academic.oup.com/eurheartj/article/39/11/942/4799042

5. Al'Aref SJ, Peña JM, Min JK . Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain. Cardiovasc Diagn Ther. 2019[acceso: 18/10/2019]; 9(1):89-93. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382654/

6. Castellano Vázquez JM. De las escalas de riesgo poblacional a la cuantificación de la ateroesclerosis subclínica: hacia un nuevo paradigma en la predicción cardiovascular. Revista Española de Cardiología. 2017[acceso: 17/09/2019];70(7):532-34. Disponible en: https://www.revespcardiol.org/es-de-las-escalas-riesgo-poblacional-articulo-S0300893217300246

7. Ibañez B, Badimon JJ, Garcia MJ. Diagnosis of Atherosclerosis by Imaging. The American Journal of Medicine. 2009 [acceso: 23/01/2019]; 122(1A):16-25. Disponible en : https://www.amjmed.com/article/S0002-9343(08)01018-8/pdf

8. Ibáñez B, Pinero A, Orejas M, Badimón JJ. Enfermedad arterial no coronaria (II) Nuevas técnicas de imagen para la cuantificación de la carga aterosclerótica global. Rev Esp Cardiol. 2007 [acceso: 26/01/2019]; 60(3):299-30. Disponible en: https://www.revespcardiol.org/es-nuevas-tecnicas-imagen-cuantificacion-carga-articulo-13100282

9. Weber LA, Cheezum MK, Reese JM, Lane AB, Haley RD, Lutz MW et al. Cardiovascular imaging for the primary prevention of atherosclerotic cardiovascular disease events. Curr Cardiovasc Imaging Rep .2015 [acceso: 14/09/2019]; 8(9):36. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534502/

10. Erbel R, Budoff M. Improvement of cardiovascular risk prediction using coronary imaging: subclinical atherosclerosis: the memory of lifetime risk factor exposure. Eur Heart J. 2012[acceso: 14/09/2019]; 33(10):1201-13. Disponible en: https://academic.oup.com/eurheartj/article/33/10/1201/486108

11. Tarkin JM, Dweck MR, Evans NR, Takx RA, Brown AJ, Tawakol H, Fayad ZA, Rudd JHF. Imaging Atherosclerosis. Circulation Research. 2016 [acceso: 12/10/2019]; 118(4):750-69. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26892971

12. Ripa RS, Kjær A. Imaging Atherosclerosis with Hybrid Positron Emission Tomography/Magnetic Resonance Imaging. Biomed Res Int. 2015[acceso: 18/10/2019]; 2015:914516. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324479/

13. Adamson PD, Newby DE. Non-invasive imaging of the coronary arteries. European Heart Journal. 2019 [acceso: 18/10/2019]; 40(29):2444-54. Disponible en: https://academic.oup.com/eurheartj/article/40/29/2444/5156200

14. Mitra N, Cernica D, Hodas R, Chițu M, Kovács I, Raț N, Benedek I. Noninvasive Imaging Biomarkers of Vulnerable Coronary Plaques- a Clinical Update. Journal of Interdisciplinary Medicine 2019[acceso: 18/10/2019]; 4(3):136-140. Disponible en: https://content.sciendo.com/view/journals/jim/4/3/article-p136.xml

15. Torres Damas EL, Igualada Correa JI. Factores de riesgos aterogénico y su relación con la lesión carotidea identificada por eco-doppler. Rev Cubana Angiol Cir Vasc. 2018[acceso: 16/09/2019]; 19(2):119-32. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1682-00372018000200006&lng=es

16. Lépori AJ, Auad L, Crespo F, Moreyra EA, Tibaldi M, Moreyra E. Concordancia entre la ecografía carotídea y la femoral para el diagnóstico de aterosclerosis subclínica en pacientes con riesgo cardiovascular bajo o intermedio. Rev Argent Cardiol. 2016 [acceso: 10/10/2019]; 84:446-52. Disponible en: https://www.sac.org.ar/wp-content/uploads/2016/12/v84n5a6-es.pd

17. Zócalo Y, Bia D. Ultrasonografía carotídea para detección de placas de ateroma y medición del espesor íntima-media; índice tobillo-brazo: evaluación no invasiva en la práctica clínica. Importancia clínica y análisis de las bases metodológicas para su evaluación. Rev Urug Cardiol. 2016 [acceso: 13/09/2019]; 31(1):[aprox. 7 pant.]. Disponible en: https://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S1688-04202016000100012

18. Naqvi TZ, Lee MS. Carotid intima-media thickness and plaque in cardiovascular risk assessment. JACC Cardiovasc Imaging. 2014 [acceso: 13/09/2019]; 7(10):1025-1038. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/25051948

19. Papageorgiou N, Briasoulis A, Androulakis E, Tousoulis D. Imaging Subclinical Atherosclerosis: Where Do We Stand? Curr Cardiol Rev. 2017 [acceso: 18/10/2019]; 13(1):47-55. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324316/

20. Zócalo Y, Bia D. Ultrasonografía carotídea para detección de placas de ateroma y medición del espesor íntima-media; índice tobillo-brazo: evaluación no invasiva en la práctica clínica. Importancia clínica y análisis de las bases metodológicas para su evaluación. Rev Urug Cardiol. 2016[acceso: 18/10/2019]; 31(1):[aprox. 7 pant.]. Disponible en https://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S1688-04202016000100012

21. Acevedo M, Krämer V, Tagle R, Arnaiz P, Corbalán R, Berríos X, et al . Perfil de riesgo cardiovascular en adultos jóvenes asintomáticos con grosor íntima media carotídeo elevado. Rev. méd. Chile 2011. [acceso: 16/09/2019]; 139(10):1322-1329. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872011001000011

22. Angels Betriu BC, Feinstein SB, Valdivielso JM, Zamorano JL, Fernández E. Papel de la ecografía carotídea en la reclasificación del riesgo cardiovascular de sujetos de riesgo bajo-intermedio. Rev Esp Cardiol [en línea]. 2013 [citado 2019 Sep 10]; 66(12):929-934. Disponible en: https://www.revespcardiol.org/es-papel-ecografia-carotidea-reclasificacion-delriesgo-articulo-resumen-S0300893213003321?redirect=true

23. Sillesen H, Muntendam P, Adourian A, Entrenki R, García M, Falk E. Carotid Plaque Burden as a Measure of Subclinical Atherosclerosis: Comparison With Other Tests for Subclinical Arterial Disease in the High Risk Plaque BioImage Study. JACC: Cardiovascular Imaging. 2012[acceso: 16/09/2019];5(7):681-9. Disponible en: https://www.sciencedirect.com/science/article/pii/S1936878X1200397X

24. Baber U, Mehran R, Sartori S, Schoos M, Sillesen H, Muntendam P, et al. Prevalence, Impact, and Predictive Value of Detecting Subclinical Coronary and Carotid Atherosclerosis in Asymptomatic Adults: The BioImage Study. Journal of the American College of Cardiology. 2015[acceso: 18/09/2019]; 65(11-24):1065-74. Disponible en: https://www.sciencedirect.com/science/article/pii/S0735109715001916

25. Den Ruijter HM, Peters SA, Anderson TJ, Britton AR, Dekker JM, Eijkemans MJ, et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA. 2012[acceso: 16/09/2019]; 308(8):796-803. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/22910757

26. Fernández-Alvira JM, Fuster V, Pocock S, Sanz J, Fernández-Friera L, Martín Laclaustra M, et al. Predicción de la aterosclerosis subclínica en individuos de bajo riesgo Puntuación de salud cardiovascular ideal y puntuación Fuster-BEWAT. JACC Ed Esp. 2017[acceso: 17/09/2019]; 70(20):70-79. Disponible en: https://pdfs.semanticscholar.org/67cb/e6eafe8c3b1809f6b0ffd5371becf1-334e58.pdf

27. Pedro-Botet J, Chillarón JJ, Benaiges D, Flores Le-Roux JA. Las guías estadounidenses de dislipemia. Fortalezas y debilidades. Revista Española de Cardiología. 2015[acceso: 15/09/2019]; 15(S1):18-21. Disponible en: https://www.revespcardiol.org/es-las-guias-estadounidenses-dislipemia-fortalezas-articulo-S1131358715701202?redirect=true

28. Brotons C, Calvo-Bonacho E, Morala I, García-Margallo MT, Cortés-Arcas MV, Puig M, et al. Impacto de las nuevas guías estadounidense y británica en el manejo y el tratamiento de las dislipemias en una población laboral española. Revista Española de Cardiología. 2014[acceso: 12/09/2019]; 67(11):906-911. Disponible en: https://www.revespcardiol.org/en-impacto-las-nuevas-guias-estadounidense-articulo-S0300893214004126?redirect=true

29. Nishimura RA, Otto CM, Bonow RO, Carabello BA, ErwinIII JP, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017 [acceso: 16/09/2019]; 135(25):1159-1195. Disponible en: https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000000503

30. Gibson AO, Blaha MJ, Arnan MK, Sacco RL, Szklo M, Herrington DM, et al. Coronary. Artery Calcium and Incident Cerebrovascular Events in an Asymptomatic Cohort: The MESA Study. JACC Cardiovascular imaging. 2014[acceso: 15/09/2019]; 7(11):1108-15. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/25459592

31. Rumberger JA, Kaufman L. A rosetta stone for coronary calcium risk stratification: agatston, volume, and mass scores in 11,490 individuals. AJR Am J Roentgenol. 2003[acceso: 16/09/2019]; 181(3):743-8. Disponible en: https://www.ajronline.org/doi/full/10.2214/ajr.181.3.1810743

32. Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol. 2007 [acceso: 16/09/2019]; 49(18):1860-70. Disponible en: https://www.onlinejacc.org/content/49/18/1860.full

33. Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE. Coronary Calcium Score and Cardiovascular Risk. J Am Coll Cardiol. 2018 [acceso: 14/09/2019]; 72(4):434-447. Disponible en: https://www.onlinejacc.org/content/72/4/434

34. Mandrola J, Foy A. The Case Against Coronary Artery Calcium Scoring for Cardiovascular Disease Risk Assessment. Am Fam Physician. 2019 [acceso: 15/09/2019]; 100(12):734-735. Disponible en: https://www.aafp.org/afp/2019/1215/p734.html

35. Han D, Hartaigh BO, Gransar H, Hyun Lee J, Rizvi A, Baskaran L, et al. Incremental prognostic value of coronary computed tomography angiography over coronary calcium scoring for major adverse cardiac events in elderly asymptomatic individuals. European Heart Journal - Cardiovascular Imaging. 2018[acceso: 13/10/2019]; 19(6):675-683. Disponible en: https://academic.oup.com/ehjcimaging/article/19/6/675/3980291

36. Naghavi M, Falk E, Hecht HS, Shah PK, SHAPE Task Force. The first SHAPE (Screening for Heart Attack Prevention and Education) guideline. Crit Pathw Cardiol. 2006 [acceso: 13/09/2019]; 5(4):187-90. Disponible en: https://ovidsp.dc2.ovid.com/sp-4.04.0a/ovidweb.cgi?T=JS&PAGE=fulltext&D=ovft&AN=00132577-200612000-00002&NEWS=N&CSC=Y&CHANNEL=PubMed

Downloads

Published

2020-10-06

How to Cite

1.
Rodríguez Perón JM. Noninvasive imaging of the atherosclerotic burden in the advanced assessment of cardiovascular risk. Rev Cubana Med Milit [Internet]. 2020 Oct. 6 [cited 2025 Jul. 1];49(4):e0200530. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/530

Issue

Vol. 49 No. 4 (2020): October - December

Section

Review Article

License

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.